ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 178 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,893,000 | +0.3% | 110,771 | +9.8% | 0.00% | -20.0% |
| Q1 2024 | $2,885,000 | +10.1% | 100,923 | +17.9% | 0.01% | +25.0% |
| Q4 2023 | $2,620,000 | +59.2% | 85,583 | +39.4% | 0.00% | +33.3% |
| Q3 2023 | $1,646,000 | -14.8% | 61,404 | +14.1% | 0.00% | -25.0% |
| Q2 2023 | $1,932,240 | +122.6% | 53,809 | +60.4% | 0.00% | +100.0% |
| Q1 2023 | $868,000 | -31.7% | 33,552 | +6.4% | 0.00% | -33.3% |
| Q4 2022 | $1,271,000 | +86.1% | 31,546 | +52.4% | 0.00% | +50.0% |
| Q3 2022 | $683,000 | +16.4% | 20,700 | +23.8% | 0.00% | 0.0% |
| Q2 2022 | $587,000 | -24.6% | 16,727 | -1.5% | 0.00% | 0.0% |
| Q1 2022 | $779,000 | -27.8% | 16,988 | +4.8% | 0.00% | 0.0% |
| Q4 2021 | $1,079,000 | +99.1% | 16,206 | +76.8% | 0.00% | +100.0% |
| Q3 2021 | $542,000 | -27.4% | 9,164 | +1.5% | 0.00% | -50.0% |
| Q2 2021 | $747,000 | +12.0% | 9,031 | -9.9% | 0.00% | 0.0% |
| Q1 2021 | $667,000 | -27.7% | 10,021 | -16.5% | 0.00% | -50.0% |
| Q4 2020 | $922,000 | +176.0% | 12,008 | +54.8% | 0.00% | +100.0% |
| Q3 2020 | $334,000 | -0.3% | 7,756 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $335,000 | +62.6% | 7,756 | +8.4% | 0.00% | +100.0% |
| Q1 2020 | $206,000 | -69.2% | 7,158 | -38.5% | 0.00% | -75.0% |
| Q4 2019 | $668,000 | +152.1% | 11,641 | +9.7% | 0.00% | +300.0% |
| Q3 2019 | $265,000 | +6.0% | 10,616 | +12.7% | 0.00% | 0.0% |
| Q2 2019 | $250,000 | +18.5% | 9,416 | -22.0% | 0.00% | 0.0% |
| Q1 2019 | $211,000 | +58.6% | 12,071 | +9.5% | 0.00% | 0.0% |
| Q4 2018 | $133,000 | -47.4% | 11,024 | -18.6% | 0.00% | -50.0% |
| Q3 2018 | $253,000 | +1481.2% | 13,548 | +35.5% | 0.00% | – |
| Q1 2017 | $16,000 | +23.1% | 10,000 | -24.5% | 0.00% | – |
| Q4 2016 | $13,000 | -85.6% | 13,250 | +7.7% | 0.00% | -100.0% |
| Q3 2016 | $90,000 | +40.6% | 12,300 | +2.5% | 0.00% | 0.0% |
| Q2 2016 | $64,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
| ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
| A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
| OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
| Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
| First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
| Virtu Financial LLC | 18,008 | $78,000 | 0.00% |